Drug intelligence / Profile preview

Viscof-S

Development stage
Unknown
Lead developer
Indus Life Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

Viscof-S is a combination cough and expectorant syrup developed by Indus Life Sciences. It is formulated to provide relief from productive (wet) coughs and chest congestion associated with respiratory conditions such as asthmatic bronchitis, bronchospasm, chronic obstructive pulmonary disease (COPD), and smoker's cough. The syrup contains four active ingredients: salbutamol (a short-acting beta-2 adrenergic receptor agonist that acts as a bronchodilator to relax airway smooth muscles), ambroxol (a mucolytic agent that breaks down thick mucus and blocks voltage-gated sodium channels), guaifenesin (an expectorant that increases the volume and reduces the viscosity of bronchial secretions), and menthol (which provides a cooling sensation to soothe throat irritation).

Brand names
Viscof-SViscof-S ExpectorantViscof-S Syrup
02

Targets

ADRB2 (β2)GRIN1 (NMDA receptor subunit 1)SCN10A (Sodium channel protein type X alpha subunit)SCN9A (Sodium channel protein type 9 subunit alpha)TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on Viscof-S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viscof-S.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call